 | Gerald Abbott
Diagnostic Imaging
Gerald Abbott, M.D., is currently conducting a study of the chronic effects of smoke inhalation in a group of survivors of a catastrophic night club fire. The study utilizes high-resolution CT scans of the lungs obtained during inspiration and expiration in order to detect evidence of small airway obstruction and other changes in the lungs that are related to smoke exposure.
Dr. Abbott is also a principal investigator in this region for the National Lung Screening Trial (NLST), a study that is designed to prove whether or not the early detection of lung cancer by CT has a beneficial effect on the rate of mortality from lung cancer. |
 | Sun Ho Ahn
Diagnostic Imaging
|
| | Michael Beland
Diagnostic Imaging
|
| | Jerrold Boxerman
Diagnostic Imaging
|
 | Jeffrey Brody
Diagnostic Imaging
|
| | Rachael Caiati
Diagnostic Imaging
|
| | John Cassese
Diagnostic Imaging
Pediatrics, Department of
|
| | Joselyn Cerezo
Diagnostic Imaging
|
| | Kevin Chang
Diagnostic Imaging
|
 | John Cronan
Diagnostic Imaging
With over 100 publications, John Cronan, M.D., is a nationally recognized expert in the field of uroradiology, ultrasound, and non-vascular interventional procedures, particularly image-guided percutaneous needle biopsies.
His clinical research has focused on the ultrasound detection of deep ven thrombosis as well as assessment of thyroid nodules with ultrasound and percutaneous biopsy. |
 | Lawrence Davis
Diagnostic Imaging
|
| | Allan Deutsch
Diagnostic Imaging
|
| | Linda Donegan
Diagnostic Imaging
|
| | Gary Dorfman
Diagnostic Imaging
|
 | Gregory Dubel
Diagnostic Imaging
|
 | Damian Dupuy
Diagnostic Imaging
Cancer treatment using image-guided techniques such as radiofrequency ablation, cryoablation and microwave ablation: These methods are used to destroy solid tumors in lung, liver, kidney, adrenal, and bone in patients who are poor candidates for conventional treatments such as surgery, chemotherapy, and radiation. These image-guided ablative methods can also be used in conjunction with standard therapies to improve cancer control. |
 | Thomas Egglin
Diagnostic Imaging
|
| | Peter Evangelista
Diagnostic Imaging
|
| | Holly Gil
Diagnostic Imaging
|
 | Richard Gold
Diagnostic Imaging
|
 | Daniel Golding
Diagnostic Imaging
|
| | David Grand
Diagnostic Imaging
|
 | Richard Alan Haas
Diagnostic Imaging
Neurosurgery
|
| | Daniel Hanson
Diagnostic Imaging
|
| | Terrance Healey
Diagnostic Imaging
|
| | Thaddeus Herliczek
Diagnostic Imaging
|
 | Mary Hillstrom
Diagnostic Imaging
|
 | Ninni Jacob
Diagnostic Imaging
|
| | Abdel Aziz Jaffan
Diagnostic Imaging
|
| | Brian Jay
Diagnostic Imaging
|
| | Mahesh Jayaraman
Diagnostic Imaging
My current research interests related to cerebrovascular disease include:
- Understanding natural history and risks associated with treatment of brain arteriovenous malformations (AVMs).
- Evaluating flow dynamics of intracranial aneurysms and their implications on future rupture risk |
| | Hanan Khalil
Diagnostic Imaging
|
 | Susan Koelliker
Diagnostic Imaging
|
| | Nathan Kohler
Diagnostic Imaging
|
| | Alexander Kowal
Diagnostic Imaging
|
 | Robert Lambiase
Diagnostic Imaging
|
 | Elizabeth Lazarus
Diagnostic Imaging
|
 | Scott Levine
Diagnostic Imaging
|
| | Ana Lourenco
Diagnostic Imaging
|
 | Martha Mainiero
Diagnostic Imaging
|
 | William Mayo-Smith
Diagnostic Imaging
|
 | Kathleen McCarten
Diagnostic Imaging
|
| | Jonathan Movson
Diagnostic Imaging
|
| | Brian Murphy
Diagnostic Imaging
|
 | Timothy Murphy
Diagnostic Imaging
Dr. Murphy is currently serving as the national co-principal investigator for the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study, the largest National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) funded multicenter randomized clinical trial examining treatment for renal artery stenosis and hypertension. He is also the national principal investigator for the largest NIH/NHLBI funded multicenter randomized clinical trial for interventional treatment of intermittent claudication (CLEVER) study. |
| | David Neumann
Diagnostic Imaging
|
| | Arthur Noel
Diagnostic Imaging
|
 | Richard Noto
Diagnostic Imaging
|
| | Ryan O'Hara
Diagnostic Imaging
|
| | John Pezzullo III
Diagnostic Imaging
|
 | Marcelle Piccolello
Diagnostic Imaging
|
| | Ethan Prince
Diagnostic Imaging
|
| | Fathima Qadeer
Diagnostic Imaging
|
 | Mark Ridlen
Diagnostic Imaging
|
 | Jeffrey Rogg
Diagnostic Imaging
|
| | Michael Ryvicker
Diagnostic Imaging
|
| | Barbara Schepps
Diagnostic Imaging
|
| | Francis Scola
Diagnostic Imaging
|
| | Bradley Shapiro
Diagnostic Imaging
|
 | Gregory Soares
Diagnostic Imaging
|
| | Julie Song
Diagnostic Imaging
|
 | Patricia Spencer
Diagnostic Imaging
|
| | Glenn Tung
Diagnostic Imaging
|
 | Michael Wallach
Diagnostic Imaging
|
| | Courtney Woodfield
Diagnostic Imaging
|
 | Don Yoo
Diagnostic Imaging
General oncologic applications with positron emission tomography (PET), especially using PET to evaluate the response to chemotherapy, radiation treatment, and image-guided techniques such as radiofrequency ablation. |
| | Abdul Zafar
Diagnostic Imaging
|
